✓
Open
27 Sep to 3 Oct, 2023
✓
Close
27 Sep to 3 Oct, 2023
3
Allotment
—
✓
Listing
Fri, Oct 6, 2023
Price Band
₹133 to ₹140
Issue Size
1,08,90,000 shares (agg. up to ₹152 Cr)
Lot Size
105 Shares
Listing Date
Fri, Oct 6, 2023
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 20.95x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 212.76 | 181.81 | 106.31 |
| Total Income | 338.77 | 293.47 | 183.78 |
| Profit After Tax | 29.00 | 27.50 | 30.59 |
| NET Worth | 100.49 | 71.46 | 88.58 |
| Total Borrowing | 59.40 | 60.68 | 0.35 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,346.00 (+0.23%) |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,546.00 (-0.06%) |
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹10.75 (+4.88%) |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹26.00 (+1.96%) |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹42.25 (-4.52%) |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹737.40 (-0.29%) |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹206.05 (-3.04%) |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹95.10 (-4.90%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in VASPL for partfinancing its capital expenditure requirements in relation to the setting up of the Proposed Facility | 80.00 |
| 2 | Investment in VASPL for funding its working capital requirements; and | 45.00 |
| 3 | General corporate purposes | 9.32 |
| Total | 134.32 |
About Valiant Laboratories IPO
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol. The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products. For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively. Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia. As of April 30, 2023, Valiant Laboratories has 86 employees.+ Read More
Contact Details
Valiant Laboratories Ltd. Address104, Udyog KshetraMulund Goregaon Link RoadMulund WestMumbai, Maharashtra, 400080+91 2249712001complianceofficer@valiantlabs.inVisit Website